Recently, attention has been called to the importance of a special variety of Graves' disease which differs from the classic variety in that the ophthalmic manifestations become dissociated from the thyrotoxic (1). The characteristics of this special type, to which we shall refer as the ophthalmopathic type of Graves' disease, are: predominantly ocular symptomatology such as diplopia, chemosis, and edema; mild or absent thyrotoxic manifestations; normal or only slightly elevated basal metabolic rate; rapid decrease in metabolic rate to substandard levels upon administration of iodine; absence or relatively slight degree of enlargement of thyroid; and positive thyrotropic assays of blood and urine. The behavior of cases of classic Graves' disease toward radioactive iodine has been studied previously (2). We will now present parallel studies on the special ophthalmopathic type.
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PROCEDURE
On the basis of previous experience (2), small doses of labelled iodine (less than 2 mgm.) were orally administered before any other treatment was given, especially before any other iodine. The thyroid iodine collection of the patient was followed by means of an externally placed Geiger-Muller counter and, in addition, urines were collected for 72 hours following the administration of the labelled iodine. (No appreciable iodine is excreted after this interval.)
The ophthalmopathic patients were compared directly with the classic type Graves' disease patients both as to thyroid collection and urinary excretion. Normal controls were also followed. The classic type patients were operated upon and the thyroid labelled iodine determined directly on the excised gland. The roid collection of labelled iodine in the ophthalmopathic group is not accurate and may be in error by as much as 50 per cent in any one case, although the composite has a smaller probable error. This error is due to individual variation in thyroid size and anatomy. The relative differentiation between the two types is borne out by the iodine excretion in the urine as shown in Figure 2 .
The initial basal metabolic rates and the final levels after complete iodinization (after the meas-31 That this is not the case is indicated by a study of the metabolic rates and the degree of response to complete iodinization. One of the distinguishing characteristics of the ophthalmopathic group is its exceptionally large response to iodinization, frequently to minus levels. A correlation study of the basal metabolic rate after iodinization shows that the rank correlation coefficient between the final basal metabolic level and the urinary excretion is -0.66 for all cases except the normal cases. This indicates that high urinary excretion of the test dose is well correlated with the level of basal metabolic response. The probability that this correlation is due to statistical fluctuation is 0.02.
Since the urinary excretion of a test dose is thus a good index of the type to which the patient belongs, this offers an additional convenient differential diagnostic aid. The use of labelled iodine for this purpose is not essential, provided that chemical methods for assaying the urinary iodine are available. Labelled iodine is merely a convenience for this purpose because of the great sensitivity and ease of the method.
SUMMARY
The ophthalmopathic type of Graves' disease patient excretes more iodine from a 2 mgm. (or less) test dose and takes up less in the thyroid than the classic Graves' disease patient. The urinary iodine excretion can be used as a diagnostic aid in distinguishing the two types of patients. 
